-
201
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
Published 2024-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
202
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids
Published 2024-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
203
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
204
189 Systematic evaluation of transcriptomic molecular features in advanced renal clear cell carcinoma treated with immunotherapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
205
Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
Published 2020-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
206
Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy
Published 2020-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
207
343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
208
535 Electroporation of B cells is correlated with cell size change during B cell expansion
Published 2020-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
209
28 Toward an automated microfluidic platform for monitoring immune response to immunotherapy
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
210
Guidelines for immunological analyses following focused ultrasound treatment
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
211
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors
Published 2024-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
212
63 Infiltration by myeloid cells is an independent prognostic biomarker in vulvar squamous cell carcinoma, associated to stem cell-like features of the tumor
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
213
911 Improved lifelines needed for all lines: real-world treatment patterns and attrition rates in US patients with non-driver mutation metastatic non-small cell lung cancer
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
214
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
215
405 Next-generation pan-cancer immunotherapy with patient-derived APC
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
216
1060 Optimally engineered IL18 Fc-fusion proteins balance potency and pharmacokinetics to promote strong anti-tumor activity
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
217
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Published 2022-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
218
9 Advanced orthotopic ovarian cancer patient-derived xenograft models for improved preclinical evaluation of immunotherapies
Published 2023-11-01“…Journal for ImmunoTherapy of Cancer…”
Article -
219
Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al
Published 2022-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
220
Inhibition of Cbl-b restores effector functions of human intratumoral NK cells
Published 2024-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article